Avantor Inc (AVTR)

$9.01 -0.05 (-0.55%)
Market Cap 6.21B
Revenue (ttm) 6.55B
Net Income (ttm) -530.20M
EPS (ttm) N/A
PE Ratio 9.77
Forward PE 11.31
Profit Margin -8.09%
Debt to Equity Ratio 0.71
Volume 7,509,745
Avg Vol 12,406,642
Day's Range N/A - N/A
Shares Out 682.06M
Stochastic %K 24%
Beta 0.94
Analysts Sell
Price Target $10.89

Company Profile

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610 386 1700
Address:
Radnor Corporate Center, Building One Suite 200 100 Matsonford Road, Radnor, United States
SaltWaterChickens
SaltWaterChickens Feb. 26 at 4:56 PM
$AVTR I’m getting EXAS vibes when EXAS was in $40 range - what happened Waiting to see if this gets pushed into the $7’s
0 · Reply
PandaSwingz
PandaSwingz Feb. 15 at 12:54 AM
$BSX $TTD $AVTR $CTSH ()1
0 · Reply
Valmaro
Valmaro Feb. 13 at 5:56 PM
$AVTR Must have….like it.
0 · Reply
dred48
dred48 Feb. 13 at 4:04 PM
$AVTR insider buy yesterday 100,000 shares at $9.40
0 · Reply
sandman7473
sandman7473 Feb. 12 at 11:54 PM
$AVTR insider transaction. Reason for ah activity?
0 · Reply
ZacksResearch
ZacksResearch Feb. 12 at 3:57 PM
$AVTR beats on earnings but faces challenges ahead! EPS of 22 cents surpassed the Zacks Consensus Estimate by 4.8%, but EPS declined year over year while revenue beat estimates. The company is grappling with operational bottlenecks and an elevated backlog, though order trends in process chemicals are encouraging. Discover the full analysis here 👉 https://www.zacks.com/stock/news/2862636/avtr-stock-plunges-despite-q4-earnings-beat-estimates-margins-decline?cid=sm-stocktwits-2-2862636-body-33311&ADID=SYND_STOCKTWITS_TWEET_2_2862636_BODY_33311
0 · Reply
ZacksResearch
ZacksResearch Feb. 12 at 2:57 PM
$AVTR beats… and still gets crushed 13%. That’s a message. Avantor topped Q4 earnings estimates, but revenues slipped, margins contracted, and the 2026 outlook signals more pressure ahead. When margins roll over and guidance tightens, the market doesn’t wait around. Is this an overreaction or the start of a tougher stretch? Get the full breakdown before making a move 👉 https://www.zacks.com/stock/news/2862636/avtr-stock-plunges-despite-q4-earnings-beat-estimates-margins-decline?cid=sm-stocktwits-2-2862636-teaser-33291&ADID=SYND_STOCKTWITS_TWEET_2_2862636_TEASER_33291
0 · Reply
TeresaTrades
TeresaTrades Feb. 12 at 2:25 PM
Largest PUT OI increases $NVDA $SMR $CMG $AVTR $GRAB
1 · Reply
PickAlpha
PickAlpha Feb. 12 at 1:23 PM
3/4: Avantor (AVTR) Q4 and 2025 results show revenue declines, $530M net loss; company launches Revival program and segment realignment | View: Reset 2025 results with declining revenue, margin compression and a large net loss increase… $AVTR $XLV $XLB $SPY
0 · Reply
d_risk
d_risk Feb. 11 at 11:31 PM
$AVTR - Avantor Inc - 10K - Updated Risk Factors AVTR’s 10-K risks are slimmer on ops, quality, IP, COVID and litigation detail, but sharper on supply chain dependence, inflation, trade and tax shifts, ESG scrutiny, leadership turnover, AI-driven innovation and cyber issues, funding cuts, tougher pricing competition, higher financing risk, and potential activist pressure. #SupplyChainDependence #ESGScrutiny #Cybersecurity #AIInnovation #InflationRisk 🟢 Added 🟠 Removed https://dev.d-risk.ai/AVTR/10-K/2026-02-11
0 · Reply
Latest News on AVTR
Avantor: The Q4 Dip Could Have Priced In All The Negatives

Feb 24, 2026, 12:32 PM EST - 2 days ago

Avantor: The Q4 Dip Could Have Priced In All The Negatives

Avantor Falls To Critical Levels As CEO Signals Investment Year Amid Soft Guidance

Feb 11, 2026, 1:42 PM EST - 15 days ago

Avantor Falls To Critical Levels As CEO Signals Investment Year Amid Soft Guidance

Avantor, Inc. (AVTR) Q4 2025 Earnings Call Transcript

Feb 11, 2026, 12:34 PM EST - 15 days ago

Avantor, Inc. (AVTR) Q4 2025 Earnings Call Transcript

Avantor® Reports Fourth Quarter and Full Year 2025 Results

Feb 11, 2026, 6:05 AM EST - 15 days ago

Avantor® Reports Fourth Quarter and Full Year 2025 Results

Longleaf Partners Global Fund 2025 Contributors And Detractors

Jan 15, 2026, 10:00 AM EST - 6 weeks ago

Longleaf Partners Global Fund 2025 Contributors And Detractors

ANGI BIO IAC MGM TIGO

Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 2:16 PM EST - 6 weeks ago

Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor

Jan 13, 2026, 7:30 AM EST - 6 weeks ago

p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor

Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Jan 12, 2026, 8:05 AM EST - 6 weeks ago

Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 8:05 AM EST - 7 weeks ago

Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference

AVTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

Dec 22, 2025, 9:54 AM EST - 2 months ago

AVTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

Avantor® Appoints Simon Dingemans to its Board of Directors

Dec 18, 2025, 8:05 AM EST - 2 months ago

Avantor® Appoints Simon Dingemans to its Board of Directors

Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and Avantor to Contact the Firm Before Upcoming Deadlines

Dec 17, 2025, 4:09 PM EST - 2 months ago

Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and Avantor to Contact the Firm Before Upcoming Deadlines

SFM

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

Dec 15, 2025, 10:43 AM EST - 2 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

AVANTOR, INC. (NYSE: AVTR) DEADLINE ALERT Bernstein Liebhard LLP Reminds Avantor, Inc. Investors of Upcoming Deadline

Dec 15, 2025, 1:45 AM EST - 2 months ago

AVANTOR, INC. (NYSE: AVTR) DEADLINE ALERT Bernstein Liebhard LLP Reminds Avantor, Inc. Investors of Upcoming Deadline

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

Dec 11, 2025, 10:03 AM EST - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

AVTR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

Dec 7, 2025, 8:17 AM EST - 2 months ago

AVTR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

Avantor® Appoints Sanjeev Mehra to its Board of Directors

Dec 4, 2025, 4:15 PM EST - 3 months ago

Avantor® Appoints Sanjeev Mehra to its Board of Directors

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. Lawsuit - AVTR

Dec 1, 2025, 8:45 AM EST - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. Lawsuit - AVTR

Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology

Nov 25, 2025, 8:05 AM EST - 3 months ago

Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology

Touchstone Mid Cap Fund Q3 2025 Portfolio Review

Nov 24, 2025, 8:55 AM EST - 3 months ago

Touchstone Mid Cap Fund Q3 2025 Portfolio Review

ALSN APH ATR AWI FIS NEU SGI

Avantor® Expands Centralized Service Center Model with Opening of Boston-Area Facility

Nov 19, 2025, 8:05 AM EST - 3 months ago

Avantor® Expands Centralized Service Center Model with Opening of Boston-Area Facility

Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer

Nov 10, 2025, 8:30 AM EST - 3 months ago

Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer

AVANTOR, INC. (NYSE: AVTR) INVESTOR ALERT Investors With Large Losses in Avantor, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Oct 31, 2025, 10:20 AM EDT - 4 months ago

AVANTOR, INC. (NYSE: AVTR) INVESTOR ALERT Investors With Large Losses in Avantor, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Avantor® Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies

Oct 30, 2025, 8:05 AM EDT - 4 months ago

Avantor® Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies

Avantor, Inc. (AVTR) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 2:56 PM EDT - 4 months ago

Avantor, Inc. (AVTR) Q3 2025 Earnings Call Transcript

Avantor Struggles With Soft Demand But Backs Long-Term Value Through Buyback

Oct 29, 2025, 11:18 AM EDT - 4 months ago

Avantor Struggles With Soft Demand But Backs Long-Term Value Through Buyback

Avantor® Reports Third Quarter 2025 Results

Oct 29, 2025, 6:05 AM EDT - 4 months ago

Avantor® Reports Third Quarter 2025 Results

Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables

Oct 23, 2025, 8:05 AM EDT - 4 months ago

Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables

Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology

Oct 15, 2025, 8:05 AM EDT - 4 months ago

Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology

Avantor® Announces Board Chairman Transition

Oct 13, 2025, 4:05 PM EDT - 4 months ago

Avantor® Announces Board Chairman Transition

Avantor® Appoints Gregory T. Lucier to its Board of Directors

Oct 3, 2025, 8:05 AM EDT - 5 months ago

Avantor® Appoints Gregory T. Lucier to its Board of Directors

Avantor® to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025

Oct 1, 2025, 8:05 AM EDT - 5 months ago

Avantor® to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025

Engine Capital takes a stake in Avantor. Activist sees several ways to create value

Aug 16, 2025, 8:19 AM EDT - 6 months ago

Engine Capital takes a stake in Avantor. Activist sees several ways to create value

Avantor® Reiterates Shareholder Value Creation Focus

Aug 11, 2025, 9:33 AM EDT - 7 months ago

Avantor® Reiterates Shareholder Value Creation Focus

SaltWaterChickens
SaltWaterChickens Feb. 26 at 4:56 PM
$AVTR I’m getting EXAS vibes when EXAS was in $40 range - what happened Waiting to see if this gets pushed into the $7’s
0 · Reply
PandaSwingz
PandaSwingz Feb. 15 at 12:54 AM
$BSX $TTD $AVTR $CTSH ()1
0 · Reply
Valmaro
Valmaro Feb. 13 at 5:56 PM
$AVTR Must have….like it.
0 · Reply
dred48
dred48 Feb. 13 at 4:04 PM
$AVTR insider buy yesterday 100,000 shares at $9.40
0 · Reply
sandman7473
sandman7473 Feb. 12 at 11:54 PM
$AVTR insider transaction. Reason for ah activity?
0 · Reply
ZacksResearch
ZacksResearch Feb. 12 at 3:57 PM
$AVTR beats on earnings but faces challenges ahead! EPS of 22 cents surpassed the Zacks Consensus Estimate by 4.8%, but EPS declined year over year while revenue beat estimates. The company is grappling with operational bottlenecks and an elevated backlog, though order trends in process chemicals are encouraging. Discover the full analysis here 👉 https://www.zacks.com/stock/news/2862636/avtr-stock-plunges-despite-q4-earnings-beat-estimates-margins-decline?cid=sm-stocktwits-2-2862636-body-33311&ADID=SYND_STOCKTWITS_TWEET_2_2862636_BODY_33311
0 · Reply
ZacksResearch
ZacksResearch Feb. 12 at 2:57 PM
$AVTR beats… and still gets crushed 13%. That’s a message. Avantor topped Q4 earnings estimates, but revenues slipped, margins contracted, and the 2026 outlook signals more pressure ahead. When margins roll over and guidance tightens, the market doesn’t wait around. Is this an overreaction or the start of a tougher stretch? Get the full breakdown before making a move 👉 https://www.zacks.com/stock/news/2862636/avtr-stock-plunges-despite-q4-earnings-beat-estimates-margins-decline?cid=sm-stocktwits-2-2862636-teaser-33291&ADID=SYND_STOCKTWITS_TWEET_2_2862636_TEASER_33291
0 · Reply
TeresaTrades
TeresaTrades Feb. 12 at 2:25 PM
Largest PUT OI increases $NVDA $SMR $CMG $AVTR $GRAB
1 · Reply
PickAlpha
PickAlpha Feb. 12 at 1:23 PM
3/4: Avantor (AVTR) Q4 and 2025 results show revenue declines, $530M net loss; company launches Revival program and segment realignment | View: Reset 2025 results with declining revenue, margin compression and a large net loss increase… $AVTR $XLV $XLB $SPY
0 · Reply
d_risk
d_risk Feb. 11 at 11:31 PM
$AVTR - Avantor Inc - 10K - Updated Risk Factors AVTR’s 10-K risks are slimmer on ops, quality, IP, COVID and litigation detail, but sharper on supply chain dependence, inflation, trade and tax shifts, ESG scrutiny, leadership turnover, AI-driven innovation and cyber issues, funding cuts, tougher pricing competition, higher financing risk, and potential activist pressure. #SupplyChainDependence #ESGScrutiny #Cybersecurity #AIInnovation #InflationRisk 🟢 Added 🟠 Removed https://dev.d-risk.ai/AVTR/10-K/2026-02-11
0 · Reply
Estimize
Estimize Feb. 11 at 11:21 PM
$AVTR reported 0.22 EPS and 1,664 revenue for Q4. http://www.estimize.com/intro/avtr?chart=historical&metric_name=eps&utm_content=AVTR&utm_
0 · Reply
Zonata
Zonata Feb. 11 at 10:09 PM
$AVTR nop, I am lucky I waited. I don't think it is a buy for 2026...maybe December... I'll keep it in watch for next Q.
0 · Reply
dred48
dred48 Feb. 11 at 4:43 PM
$AVTR not a good report and guidance is poor…2026 looks like will be a lost transition year… my avg. cost is 12.07 so will hold and hope this is not a value trap…
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Feb. 11 at 3:42 PM
$AVTR all the insider buys, new board members etc fooled me they don't mean shi+ though with that er not even sure its time to take some
1 · Reply
sandman7473
sandman7473 Feb. 11 at 2:43 PM
$AVTR added.
0 · Reply
LIVE_Trading
LIVE_Trading Feb. 11 at 2:40 PM
bought $AVTR $SPY
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 11 at 1:36 PM
$AVTR (-14.1% pre) Avantor (NYSE:AVTR) Surprises With Q4 CY2025 Sales But Stock Drops https://ooc.bz/l/92895
0 · Reply
mikesterz7
mikesterz7 Feb. 11 at 12:44 PM
$AVTR Earnings beat
0 · Reply
sandman7473
sandman7473 Feb. 11 at 12:43 PM
$AVTR inline and a beat. Calls carried over.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 11 at 12:37 PM
$AVTR Q4 '25 Earnings Results & Recap Avantor reported net sales of $6.55B for fiscal year 2025, marking a 3.4% decline, including a 2.8% organic net sales decrease. The company posted a net loss of $530.2M.
0 · Reply
sandman7473
sandman7473 Feb. 10 at 7:05 PM
$AVTR calls hitting the tape. Reports tomorrow. Watching.
0 · Reply
_TP888
_TP888 Feb. 10 at 6:18 PM
$AVTR | $12.00 | Call | Premium: $150,193
0 · Reply